Notice of Change to RFA-DA-21-016, "Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)"
Notice Number:
NOT-DA-21-057

Key Dates

Release Date:

January 29, 2021

Related Announcements

RFA-DA-21-016 - Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform interested applicants of a change to the Advisory Council Review date to Funding Opportunity Announcement (FOA) RFA-DA-21-016, "Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)".

Part 1. Overview Information

Key Dates


Currently Reads: 

Advisory Council Review October 2021

Revised to Read: 

Advisory Council Review August 2021

All other aspects of this FOA remain unchanged.


 

Inquiries

Please direct all inquiries to:

Julia Berzhanskaya, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-594-6140
Email: julia.berzhanskaya@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices